Clinical Trial

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-10
notable Primary completion pushed: 2027-04-06 -> 2027-06-10 2026-07-10
minor Completion pushed: 2027-04-06 -> 2027-06-10 2026-07-10
Trial Details
NCT Number NCT07527143
Lead Sponsor Mayo Clinic
Conditions Endometrial Carcinoma
Enrollment 25 participants
Start Date 2026-06-10
Primary Completion 2027-06-10 (estimated)
Study Completion 2027-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-09